Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)

NCT02860858 is registered in ClinicalTrials.gov with Department of Medical Services Ministry of Public Health of Thailand as lead sponsor.

NCT NCT02860858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02860858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)
Lead sponsor
Department of Medical Services Ministry of Public Health of Thailand
Phase
Phase 4
Overall status
Completed
Start date
December 30, 2016
Completion date
December 31, 2018
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

symtomatic macular polypoidal choroidal vasculopathy